Iterum Therapeutics plc (NASDAQ:ITRM) filed a Form 8-K with the Securities and Exchange Commission on February 18, 2026, disclosing a material event. Iterum Therapeutics plc's…
Iterum Therapeutics plc (NASDAQ:ITRM) filed a Form 8-K with the Securities and Exchange Commission on February 18, 2026, disclosing a material event.
Iterum Therapeutics plc's stock currently trades at $0.24 with a market capitalization of $22.6M. The Healthcare company's stock moved following the disclosure.
Current market data
NASDAQ · ITRM
$0.03
Down: -$0.00 · -10.98%
Live quote updated
Keep reading
earnings ·
earnings ·
earnings ·
earnings ·
